BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15852217)

  • 21. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
    Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
    Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gene polymorphisms in ATP (purinergic) receptors and pain sensitivity].
    Ide S; Minami M; Ikeda K
    Masui; 2009 Sep; 58(9):1122-9. PubMed ID: 19764435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purinoceptor subtypes mediating contraction and relaxation of marmoset urinary bladder smooth muscle.
    McMurray G; Dass N; Brading AF
    Br J Pharmacol; 1998 Apr; 123(8):1579-86. PubMed ID: 9605564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple P2X and P2Y receptor subtypes in mouse J774, spleen and peritoneal macrophages.
    Coutinho-Silva R; Ojcius DM; Górecki DC; Persechini PM; Bisaggio RC; Mendes AN; Marks J; Burnstock G; Dunn PM
    Biochem Pharmacol; 2005 Feb; 69(4):641-55. PubMed ID: 15670583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet activation by ADP: the role of ADP antagonists.
    Gachet C
    Ann Med; 2000 Dec; 32 Suppl 1():15-20. PubMed ID: 11209975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2.
    Alvarado-Castillo C; Harden TK; Boyer JL
    Mol Pharmacol; 2005 Jan; 67(1):114-22. PubMed ID: 15496502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia.
    Bianco F; Fumagalli M; Pravettoni E; D'Ambrosi N; Volonte C; Matteoli M; Abbracchio MP; Verderio C
    Brain Res Brain Res Rev; 2005 Apr; 48(2):144-56. PubMed ID: 15850653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of extracellular purines and pyrimidines on human airway smooth muscle cells.
    Govindaraju V; Martin JG; Maghni K; Ferraro P; Michoud MC
    J Pharmacol Exp Ther; 2005 Nov; 315(2):941-8. PubMed ID: 16099930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Purinergic signals].
    Lazarowski ER; Schwarzbaum PJ
    Medicina (B Aires); 2009; 69(2):267-76. PubMed ID: 19435702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of multiple receptors in the actions of extracellular ATP: the example of vascular endothelial cells.
    Motte S; Communi D; Pirotton S; Boeynaems JM
    Int J Biochem Cell Biol; 1995 Jan; 27(1):1-7. PubMed ID: 7757878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nucleotide receptors--structure and function, history and perspectives].
    Barańska J
    Postepy Biochem; 2014; 60(4):424-37. PubMed ID: 25807822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of platelet functions by P2 receptors.
    Gachet C
    Annu Rev Pharmacol Toxicol; 2006; 46():277-300. PubMed ID: 16402906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signaling at purinergic P2X receptors.
    Surprenant A; North RA
    Annu Rev Physiol; 2009; 71():333-59. PubMed ID: 18851707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleotides regulate NaCl transport in mIMCD-K2 cells via P2X and P2Y purinergic receptors.
    McCoy DE; Taylor AL; Kudlow BA; Karlson K; Slattery MJ; Schwiebert LM; Schwiebert EM; Stanton BA
    Am J Physiol; 1999 Oct; 277(4):F552-9. PubMed ID: 10516279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autocrine purinergic receptor signaling is essential for macrophage chemotaxis.
    Kronlage M; Song J; Sorokin L; Isfort K; Schwerdtle T; Leipziger J; Robaye B; Conley PB; Kim HC; Sargin S; Schön P; Schwab A; Hanley PJ
    Sci Signal; 2010 Jul; 3(132):ra55. PubMed ID: 20664064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An elusive receptor is finally caught: P2Y(12'), an important drug target in platelets.
    Barnard EA; Simon J
    Trends Pharmacol Sci; 2001 Aug; 22(8):388-91. PubMed ID: 11478981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in signalling by extracellular nucleotides. the role and transduction mechanisms of P2Y receptors.
    Communi D; Janssens R; Suarez-Huerta N; Robaye B; Boeynaems JM
    Cell Signal; 2000 Jun; 12(6):351-60. PubMed ID: 10889463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P2Y receptors: focus on structural, pharmacological and functional aspects in the brain.
    Fischer W; Krügel U
    Curr Med Chem; 2007; 14(23):2429-55. PubMed ID: 17979698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular nucleotide signaling in the inner ear.
    Housley GD
    Mol Neurobiol; 1998 Feb; 16(1):21-48. PubMed ID: 9554700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular physiology of P2 receptors in the central nervous system.
    Illes P; Alexandre Ribeiro J
    Eur J Pharmacol; 2004 Jan; 483(1):5-17. PubMed ID: 14709321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.